Abstract
Ammonia is a neurotoxic compound which is detoxified through liver enzymes from urea cycle. Several inherited or acquired conditions can elevate ammonia concentrations in blood, causing severe damage to the central nervous system due to the toxic effects exerted by ammonia on the astrocytes. Therefore, hyperammonemic patients present potentially life-threatening neuropsychiatric symptoms, whose severity is related with the hyperammonemia magnitude and duration, as well as the brain maturation stage. Inherited metabolic diseases caused by enzymatic defects that compromise directly or indirectly the urea cycle activity are the main cause of hyperammonemia in the neonatal period. These diseases are mainly represented by the congenital defects of urea cycle, classical organic acidurias, and the defects of mitochondrial fatty acids oxidation, with hyperammonemia being more severe and frequent in the first two groups mentioned. An effective and rapid treatment of hyperammonemia is crucial to prevent irreversible neurological damage and it depends on the understanding of the pathophysiology of the diseases, as well as of the available therapeutic approaches. In this review, the mechanisms underlying the hyperammonemia and neurological dysfunction in urea cycle disorders, organic acidurias, and fatty acids oxidation defects, as well as the therapeutic strategies for the ammonia control will be discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
References
Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK (2009) Efficacy of l-ornithine l-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 136(7):2159–2168. https://doi.org/10.1053/j.gastro.2009.02.050
Ah Mew N, Caldovic L (2011) N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment. Appl Clin Genet 4:127–135. https://doi.org/10.2147/TACG.S12702
Albrecht J, Norenberg MD (2006) Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 44(4):788–794. https://doi.org/10.1002/hep.21357
Alger BE, Nicoll RA (1983) Ammonia does not selectively block IPSPs in rat hippocampal pyramidal cells. J Neurophysiol 49(6):1381–1391. https://doi.org/10.1152/jn.1983.49.6.1381
Anderson DR, Viau K, Botto LD, Pasquali M, Longo N (2020) Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab 129:13–19. https://doi.org/10.1016/j.ymgme.2019.11.006
Arbeiter AK, Kranz B, Wingen AM, Bonzel KE, Dohna-Schwake C, Hanssler L, Neudorf U, Hoyer PF, Büscher R (2010) Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transpl 25(4):1257–1265. https://doi.org/10.1093/ndt/gfp595
Ashley SN, Nordin JML, Buza EL, Greig JA, Wilson JM (2018) Adeno-associated viral gene therapy corrects a mouse model of argininosuccinic aciduria. Mol Genet Metab 125:241–250. https://doi.org/10.1016/j.ymgme.2018.08.013
Auron A, Brophy PD (2012) Hyperammonemia in review: pathophysiology, diagnosis, and treatment. Pediatr Nephrol 27(2):207–222. https://doi.org/10.1007/s00467-011-1838-5
Bachmann C (2003) Long-term outcome of patients with urea cycle disorders and the question of neonatal screening. Eur J Pediatr 162(Suppl 1):S29-33. https://doi.org/10.1007/s00431-003-1347-z
Bachmann C, Colombo JP, Jaggi K (1982) N-acetylglutamate synthetase (NAGS) deficiency: diagnosis, clinical observations and treatment. Adv Exp Med Biol 153:39–45. https://doi.org/10.1007/978-1-4757-6903-6_6
Bachmann C, Braissant O, Villard AM, Boulat O, Henry H (2004) Ammonia toxicity to the brain and creatine. Mol Genet Metab 81(Suppl 1):S52–S57. https://doi.org/10.1016/j.ymgme.2003.10.014
Bakouh N, Benjelloun F, Cherif-Zahar B, Planelles G (2006) The challenge of understanding ammonium homeostasis and the role of the Rh glycoproteins. Transfus Clin Biol 13(1–2):139–146. https://doi.org/10.1016/j.tracli.2006.02.008
Batshaw ML, MacArthur RB, Tuchman M (2001) Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr 138(1 Suppl):S46-54. https://doi.org/10.1067/mpd.2001.111836
Bemeur C, Cudalbu C, Dam G, Thrane AS, Cooper AJ, Rose CF (2016) Brain edema: a valid endpoint for measuring hepatic encephalopathy? Metab Brain Dis 31:1249–1258. https://doi.org/10.1007/s11011-016-9843-9
Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J (2007) Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46(6):1844–1852. https://doi.org/10.1002/hep.21838
Blau N, Duran M, Gibson KM, Dionisi-Vici C (2014) Physician’s guide to the diagnosis, treatment and follow-up of inherited metabolic diseases. Springer, Berlin
Bosoi CR, Rose CF (2009) Identifying the direct effects of ammonia on the brain. Metab Brain Dis 24(1):95–102. https://doi.org/10.1007/s11011-008-9112-7
Bosoi CR, Zwingmann C, Marin H, Parent-Robitaille C, Huynh J, Tremblay M, Rose CF (2014) Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. J Hepatol 60(3):554–560. https://doi.org/10.1016/j.jhep.2013.10.011
Bowie A, O’Neill LA (2000) The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 67(4):508–514. https://doi.org/10.1002/jlb.67.4.508
Braissant O, Honegger P, Loup M, Iwase K, Takiguchi M, Bachmann C (1999) Hyperammonemia: regulation of argininosuccinate synthetase and argininosuccinate lyase genes in aggregating cell cultures of fetal rat brain. Neurosci Lett 266(2):89–92. https://doi.org/10.1016/S0304-3940(99)00274-8
Braissant O, McLin VA, Cudalbu C (2013) Ammonia toxicity to the brain. J Inherit Metab Dis 36(4):595–612. https://doi.org/10.1007/s10545-012-9546-2
Brassier A, Gobin S, Arnoux JB et al (2015) Long-term outcomes in ornithine transcarbamylase deficiency: a series of 90 patients. Orphanet J Rare Dis 10:58. https://doi.org/10.1186/s13023-015-0266-1
Brookes N, Turner RJ (1993) Extracellular potassium regulates the glutamine content of astrocytes: mediation by intracellular pH. Neurosci Lett 160(1):73–76. https://doi.org/10.1016/0304-3940(93)9002-7
Brunetti-Pierri N, Clarke C, Mane V, Palmer DJ, Lanpher B, Sun Q, O’Brien W, Lee B (2008) Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors. J Gene Med 10(8):890–896. https://doi.org/10.1002/jgm.1218
Brusilow SW, Maestri NE (1996) Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 43:127–170
Busa WB, Nuccitelli R (1984) Metabolic regulation via intracellular pH. Am J Physiol 246(4 Pt 2):R409–R438. https://doi.org/10.1152/ajpregu.1984.246.4.R409
Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17(4):221–227. https://doi.org/10.1023/A:1021989230535
Butterworth RF (2011) Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets. Neurochem Int 59(6):830–836. https://doi.org/10.1016/j.neuint.2011.07.014
Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT (2009) Members of the ISHEN commission on experimental models of HE. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 29(6):783–788. https://doi.org/10.1111/j.1478-3231.2009.02034.x
Cagnon L, Braissant O (2007) Hyperammonemia-induced toxicity for the developing central nervous system. Brain Res Rev 56:183–197. https://doi.org/10.1016/j.brainresrev.2007.06.026
Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29(3):648–653. https://doi.org/10.1002/hep.510290309
Cooper AJ (2001) Role of glutamine in cerebral nitrogen metabolism and ammonia neurotoxicity. Ment Retard Dev Disabil Res Rev 7:280–286. https://doi.org/10.1002/mrdd.1039
Cooper AJ, Plum F (1987) Biochemistry and physiology of brain ammonia. Physiol Rev 67(2):440–519. https://doi.org/10.1152/physrev.1987.67.2.440
Cooper AJL, Mora SN, Cruz NF, Gelbard AS (1985) Cerebral ammonia metabolism in hyperammonemic rats. J Neurochem 44(6):1716–1723. https://doi.org/10.1111/j.1471-4159.1985.tb07159.x
Corkey BE, Hale DE, Glennon MC, Kelley RI, Coates PM, Kilpatrick L, Stanley CA (1988) Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome. J Clin Invest 82:782–788. https://doi.org/10.1172/JCI113679
Corvi MM, Soltys CL, Berthiaume LG (2001) Regulation of mitochondrial carbamoyl-phosphate synthetase 1 activity by active site fatty acylation. J Biol Chem 276:45704–45712. https://doi.org/10.1074/jbc.M102766200
Cudalbu C (2013) In vivo studies of brain metabolism in animal models of hepatic encephalopathy using 1H magnetic resonance spectroscopy. Metab Brain Dis 28(2):167–174. https://doi.org/10.1007/s11011-012-9368-9
Dam G, Ott P, Aagaard NK, Vilstrup H (2013) Branched-chain amino acids and muscle ammonia detoxification in cirrhosis. Metab Brain Dis 28(2):217–220. https://doi.org/10.1007/s11011-013-9377-3
Dasarathy S, Mookerjee RP, Rackayova V, Rangroo Thrane V, Vairappan B, Ott P, Rose CF (2017) Ammonia toxicity: from head to toe? Metab Brain Dis 32(2):529–538. https://doi.org/10.1007/s11011-016-9938-3
Delwing D, Delwing D, Bavaresco CS, Wyse AT (2008) Protective effect of nitric oxide synthase inhibition or antioxidants on brain oxidative damage caused by intracerebroventricular arginine administration. Brain Res 1193:120–127. https://doi.org/10.1016/j.brainres.2007.11.052
Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C(2):104–112. https://doi.org/10.1002/ajmg.c.30090
Dercksen M, Ijlst L, Duran M, Mienie LJ, van Cruchten A, vander Westhuizen FH, Wanders RJ, (2014) Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters. Biochim Biophys Acta 1842:2510–2516. https://doi.org/10.1016/j.bbadis.2013.04.027
Di Donato S, Rimoldi M, Garavaglia B, Uziel G (1984) Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency. Clin Chim Acta 139(1):13–21. https://doi.org/10.1016/0009-8981(84)90187-6
Diaz GA, Krivitzky LS, Mokhtarani M, Rhead W, Bartley J, Feigenbaum A, Longo N, Berquist W, Berry SA, Gallagher R, Lichter-Konecki U, Bartholomew D, Harding CO, Cederbaum S, McCandless SE, Smith W, Vockley G, Bart SA, Korson MS, Kronn D, Zori R, Merritt JL (2013) Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate. Hepatology 57:2171–2179. https://doi.org/10.1002/hep.26058
Diez-Fernandez C, Häberle J (2017) Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder. Expert Opin Ther Targets 21(4):391–399. https://doi.org/10.1080/14728222.2017.1294685
Dimmock D, Maranda B, Dionisi-Vici C, Wang J, Kleppe S, Fiermonte G, Bai R, Hainline B, Hamosh A, O’Brien WE, Scaglia F, Wong LJ (2009) Citrin deficiency, a perplexing global disorder. Mol Genet Metab 96(1):44–49. https://doi.org/10.1016/j.ymgme.2008.10.007
Dionisi-Vici C, Deodato F, Röschinger W, Rhead W, Wilcken B (2006) “Classical” organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29(2–3):383–389. https://doi.org/10.1007/s10545-006-0278-z
Eguchi K, Izumi Y, Yasuoka Y, Nakagawa T, Ono M, Maruyama K, Matsuo N, Hiramatsu A, Inoue H, Nakayama Y, Nonoguchi H, Lee HW, Weiner ID, Kakizoe Y, Kuwabara T, Mukoyama M (2021) Regulation of Rhcg, an ammonia transporter, by aldosterone in the kidney. J Endocrinol 249(2):95–112. https://doi.org/10.1530/JOE-20-0267
Engel K, Höhne W, Häberle J (2009) Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene. Hum Mutat 30(3):300–307. https://doi.org/10.1002/humu.20847
Enns GM (2008) Neurologic damage and neurocognitive dysfunction in urea cycle disorders. Semin Pediatr Neurol 15(3):132–139. https://doi.org/10.1016/j.spen.2008.05.007
Feillet F, Steinmann G, Vianey-Saban C et al (2003) Adult presentation of MCAD deficiency revealed by coma and severe arrythmias. Intensive Care Med 29(9):1594–1597. https://doi.org/10.1007/s00134-003-1871-3
Felipo V, Butterworth RF (2002) Neurobiology of ammonia. Prog Neurobiol 67:259–279. https://doi.org/10.1016/S0301-0082(02)00019-9
Fiati Kenston SS, Song X, Li Z, Zhao J (2019) Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy. J Gastroenterol Hepatol 34(1):31–39. https://doi.org/10.1111/jgh.14408
Filipowicz HR, Ernst SL, Ashurst CL, Pasquali M, Longo N (2006) Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol Genet Metab 88:123–130. https://doi.org/10.1016/j.ymgme.2005.11.016
Filippi L, Gozzini E, Fiorini P, Malvagia S, la Marca G, Donati MA (2010) N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatology 97(3):286–290. https://doi.org/10.1159/000255168
Ganz R, Swain M, Traber P, DalCanto M, Butterworth RF, Blei AT (1989) Ammonia-induced swelling of rat cerebral cortical slices: implications for the pathogenesis of brain edema in acute hepatic failure. Metab Brain Dis 4(3):213–223. https://doi.org/10.1007/BF01000297
Goulenok C, Bernard B, Cadranel JF, Thabut D, Di Martino V, Opolon P, Poynard T (2002) Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Aliment Pharmacol Ther 16(3):361–372. https://doi.org/10.1046/j.1365-2036.2002.01191.x
Graham TE, MacLean DA (1992) Ammonia and amino acid metabolism in human skeletal muscle during exercise. Can J Physiol Pharmacol 70(1):132–141. https://doi.org/10.1139/y92-020
Gregorios JB, Mozes LW, Norenberg MD (1985a) Morphologic effects of ammonia on primary astrocyte cultures. II. Electron microscopic studies. J Neuropathol Exp Neurol 44(4):404–414. https://doi.org/10.1097/00005072-198507000-00004
Gregorios JB, Mozes LW, Norenberg LO, Norenberg MD (1985b) Morphologic effects of ammonia on primary astrocyte cultures. I. Light microscopic studies. J Neuropathol Exp Neurol 44(4):397–403. https://doi.org/10.1097/00005072-198507000-00003
Gropman AL, Summar M, Leonard JV (2007) Neurological implications of urea cycle disorders. J Inherit Metab Dis 30(6):865–879. https://doi.org/10.1007/s10545-007-0709-5
Guffon N, Vianey-Saban C, Bourgeois J, Rabier D, Colombo JP, Guibaud P (1995) A new neonatal case of N-acetylglutamate synthase deficiency treated by carbamylglutamate. J Inherit Metab Dis 18:61–65. https://doi.org/10.1007/BF00711374
Häberle J (2013a) Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. Arch Biochem Biophys 536:101–108. https://doi.org/10.1016/j.abb.2013.04.009
Häberle J (2013b) Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. Arch Biochem Biophys 536(2):101–108. https://doi.org/10.1016/j.abb.2013.04.009
Häberle J, Pauli S, Schmidt E, Schulze-Eilfing B, Berning C, Koch HG (2003) Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1). Mol Genet Metab 80(3):302–306. https://doi.org/10.1016/j.ymgme.2003.08.002
Häberle J, Chakrapani A, Ah Mew N, Longo N (2018) Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories. Orphanet J Rare Dis 13(1):219. https://doi.org/10.1186/s13023-018-0963-7
Häberle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, Mandel H, Martinelli D, Pintos-Morell G, Santer R, Skouma A, Servais A, Tal G, Rubio V, Huemer M, Dionisi-Vici C (2019) Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis 42(6):1192–1230. https://doi.org/10.1002/jimd.12100
Halestrap AP, Woodfield KY, Connern CP (1997) Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 272(6):3346–3354. https://doi.org/10.1074/jbc.272.6.3346
Herrera Sanchez MB, Previdi S, Bruno S, Fonsato V, Deregibus MC, Kholia S et al (2017) Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency. Stem Cell Res Ther 8:176. https://doi.org/10.1186/s13287-017-0628-9
Hertz L, Zielke HR (2004) Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci 27(12):735–743. https://doi.org/10.1016/j.tins.2004.10.008
Horiuchi M, Kobayashi K, Tomomura M, Kuwajima M, Imamura Y, Koizumi T, Nikaido H, Hayakawa J, Saheki T (1992) Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription. J Biol Chem 267(8):5032–5035
Houten SM, Violante S, Ventura FV, Wanders RJ (2016) The biochemistry and physiology of mitochondrial fatty acid β-oxidation and its genetic disorders. Annu Rev Physiol 78:23–44. https://doi.org/10.1146/annurev-physiol-021115-105045
Jackson MJ, Beaudet AL, O’Brien WE (1986) Mammalian urea cycle enzymes. Annu Rev Genet 20:431–464. https://doi.org/10.1146/annurev.ge.20.120186.002243
Jayakumar AR, Rama Rao KV, Schousboe A, Norenberg MD (2004) Glutamine-induced free radical production in cultured astrocytes. Glia 46(3):296–301. https://doi.org/10.1002/glia.20003
Jayakumar AR, Liu M, Moriyama M, Ramakrishnan R, Forbush B 3rd, Reddy PV, Norenberg MD (2008) Na–K–Cl Cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling. J Biol Chem 283(49):33874–33882. https://doi.org/10.1074/jbc.M804016200
Jiang W, Desjardins P, Butterworth RF (2009a) Hypothermia attenuates oxidative/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure. Neurochem Int 55(1–3):124–128. https://doi.org/10.1016/j.neuint.2009.02.007
Jiang W, Desjardins P, Butterworth RF (2009b) Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia. J Cereb Blood Flow Metab 29(5):944–952. https://doi.org/10.1038/jcbfm.2009.18
Kang E, Kim YM, Kang M, Heo SH, Kim GH, Choi IH, Choi JH, Yoo HW, Lee BH (2018) Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening. BMC Pediatr 18(1):103. https://doi.org/10.1186/s12887-018-1069-z
Kasapkara CS, Ezgu FS, Okur I, Tumer L, Biberoglu G, Hasanoglu A (2011) N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia. Eur J Pediatr 170(6):799–801. https://doi.org/10.1007/s00431-010-1362-9
Kato M, Hughes RD, Keays RT, Williams R (1992) Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 15:1060–1066. https://doi.org/10.1002/hep.1840150615
Kazak F, Yarim GF (2017) Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: involvement of brain-derived neurotrophic factor. Neurosci Lett 658:32–36. https://doi.org/10.1016/j.neulet.2017.07.059
Kelly T, Kafitz KW, Roderigo C, Rose CR (2009) Ammonium-evoked alterations in intracellular sodium and pH reduce glial glutamate transport activity. Glia 57(9):921–934. https://doi.org/10.1002/glia.20817
Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M, Yoshino M, Shigematsu Y, Yorifuji T, Kasahara M, Horikawa R, Endo F (2012) Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis 35(5):777–785
Kido J, Matsumoto S, Mitsubuchi H, Endo F, Nakamura K (2018) Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment. Metab Brain Dis 33(5):1517–1523. https://doi.org/10.1007/s11011-018-0259-6
Kido J, Matsumoto S, Häberle J, Nakajima Y, Wada Y, Mochizuki N, Murayama K, Lee T, Mochizuki H, Watanabe Y, Horikawa R, Kasahara M, Nakamura K (2021a) Long-term outcome of urea cycle disorders: report from a nationwide study in Japan. J Inherit Metab Dis 44(4):826–837. https://doi.org/10.1002/jimd.12384
Kido J, Matsumoto S, Häberle J, Inomata Y, Kasahara M, Sakamoto S, Horikawa R, Tanemura A, Okajima H, Suzuki T, Nakamura K (2021b) Role of liver transplantation in urea cycle disorders: report from a nationwide study in Japan. J Inherit Metab Dis. https://doi.org/10.1002/jimd.12415
Kim IK, Niemi AK, Krueger C, Bonham CA, Concepcion W, Cowan TM, Enns GM, Esquivel CO (2013) Liver transplantation for urea cycle disorders in pediatric patients: a single-center experience. Pediatr Transpl 17(2):158–167. https://doi.org/10.1111/petr.12041
Kircheis G (2016) Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of l-ornithine-l-aspartate in the management of HE. Metab Brain Dis 31(6):1365–1367. https://doi.org/10.1007/s11011-016-9912-0
Kölker S, Burgard P, Sauer SW, Okun JG (2013) Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation. J Inherit Metab Dis 36:635–644. https://doi.org/10.1007/s10545-013-9600-8
Kölker S, Garcia-Cazorla A, Valayannopoulos V, Lund AM, Burlina AB, Sykut-Cegielska J, Wijburg FA, Teles EL, Zeman J, Dionisi-Vici C, Barić I, Karall D, Augoustides-Savvopoulou P, Aksglaede L, Arnoux JB, Avram P, Baumgartner MR, Blasco-Alonso J, Chabrol B, Chakrapani A, Chapman K, Saladelafont I (2015) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis 38:1041–1057. https://doi.org/10.1007/s10545-015-9839-3
Kosenko E, Kaminsky Y, Kaminsky A, Valencia M, Lee L, Hermenegildo C, Felipo V (1997) Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic Res 27(6):637–644. https://doi.org/10.3109/10715769709097867
Kowaltowski AJ, Castilho RF, Vercesi AE (2001) Mitochondrial permeability transition and oxidative stress. FEBS Lett 495(1–2):12–15. https://doi.org/10.1016/S0014-5793(01)02316-X
Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81(2):807–869. https://doi.org/10.1152/physrev.2001.81.2.807
Lai JC, Cooper AJ (1986) Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem 47(5):1376–1386. https://doi.org/10.1111/j.1471-4159.1986.tb00768.x
Lee B, Dennis JA, Healy PJ, Mull B, Pastore L, Yu H, Aguilar-Cordova E, O’Brien W, Reeds P, Beaudet AL (1999) Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia. Proc Natl Acad Sci USA 96(7):3981–3986. https://doi.org/10.1073/pnas.96.7.3981
Leise MD, Poterucha JJ, Kamath PS, Kim WR (2014) Management of hepatic encephalopathy in the hospital. Mayo Clin Proc 89(2):241–253. https://doi.org/10.1016/j.mayocp.2013.11.009
Leonard JV, McKiernan PJ (2004) The role of liver transplantation in urea cycle disorders. Mol Genet Metab 81(Suppl 1):S74–S78. https://doi.org/10.1016/j.ymgme.2003.08.027
Lichter-Konecki U, Diaz GA, Merritt JL 2nd, Feigenbaum A, Jomphe C, Marier JF, Beliveau M, Mauney J, Dickinson K, Martinez A, Mokhtarani M, Scharschmidt B, Rhead W (2011) Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate. Mol Genet Metab 103(4):323–329. https://doi.org/10.1016/j.ymgme.2011.04.013
Lichter-Konecki U, Caldovic L, Morizono H, Simpson K (2016) Ornithine transcarbamylase deficiency. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) GeneReviews. University of Washington, Seattle, pp 1993–2021
Limketkai B, Zucker S (2008) Hyperammonemic encephalopathy caused by carnitine deficiency. J Gen Intern Med 23(2):210–213. https://doi.org/10.1007/s11606-007-0473-0
Liu E, MacKenzie T, Dobyns EL, Parikh CR, Karrer FM, Narkewicz MR, Sokol RJ (2006) Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol 44(1):134–141. https://doi.org/10.1016/j.jhep.2005.06.021
Lu YB, Kobayashi K, Ushikai M, Tabata A, Iijima M, Li MX et al (2005) Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J Hum Genet 50:338–346. https://doi.org/10.1007/s10038-005-0262-8
Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G (2011) Acetyl-l-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis 26(4):281–289. https://doi.org/10.1007/s11011-011-9260-z
Maldonado C, Guevara N, Silveira A, Fagiolino P, Vázquez M (2017) l-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: a case report. J Int Med Res 45(3):1268–1272
Marcaggi P, Jeanne M, Coles JA (2004) Neuron-glial trafficking of NH4+ and K+: separate routes of uptake into glial cells of bee retina. Eur J Neurosci 19(4):966–976. https://doi.org/10.1111/j.0953-816X.2004.03165.x
Marcaida G, Felipo V, Hermenegildo C, Miñana MD, Grisolía S (1992) Acute ammonia toxicity is mediated by the NMDA type of glutamate receptors. FEBS Lett 296(1):67–68. https://doi.org/10.1016/0014-5793(92)80404-5
Marcaida G, Miñana MD, Burgal M, Grisolía S, Felipo V (1995) Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures. Eur J Neurosci 7(12):2389–2396. https://doi.org/10.1111/j.1460-9568.1995.tb01036.x
Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184(3):1155–1160. https://doi.org/10.1084/jem.184.3.1155
Marisco Pda C, Ribeiro MC, Bonini JS, Lima TT, Mann KC, Brenner GM, Dutra-Filho CS, Mello CF (2003) Ammonia potentiates methylmalonic acid-induced convulsions and TBARS production. Exp Neurol 182(2):455–460. https://doi.org/10.1016/S0014-4886(03)00113-4
Martinelli D, Diodato D, Ponzi E, Monné M, Boenzi S, Bertini E, Fiermonte G, Dionisi-Vici C (2015) The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Orphanet J Rare Dis 10:29. https://doi.org/10.1186/s13023-015-0242-9
Matoori S, Leroux JC (2015) Recent advances in the treatment of hyperammonemia. Adv Drug Deliv Rev 90:55–68. https://doi.org/10.1016/j.addr.2015.04.009
Meyburg J, Hoffmann GF (2010) Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol Genet Metab 100(Suppl 1):S77-83. https://doi.org/10.1016/j.ymgme.2010.01.011
Monfort P, Cauli O, Montoliu C, Rodrigo R, Llansola M, Piedrafita B, El Mlili N, Boix J, Agustí A, Felipo V (2009) Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications. Neurochem Int 55(1–3):106–112. https://doi.org/10.1016/j.neuint.2009.01.021
Morris AA, Richmond SW, Oddie SJ, Pourfarzam M, Worthington V, Leonard JV (1998) N-acetylglutamate synthetase deficiency: favourable experience with carbamylglutamate. J Inherit Metab Dis 21(8):867–868. https://doi.org/10.1023/A:1005478904186
Moscioni D, Morizono H, McCarter RJ, Stern A, Cabrera-Luque J, Hoang A, Sanmiguel J, Wu D, Bell P, Gao GP, Raper SE, Wilson JM, Batshaw ML (2006) Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors. Mol Ther 14(1):25–33. https://doi.org/10.1016/j.ymthe.2006.03.009
Moser H (1987) Electrophysiological evidence for ammonium as a substitute for potassium in activating the sodium pump in a crayfish sensory neuron. Can J Physiol Pharmacol 65(2):141–145. https://doi.org/10.1139/y87-028
Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED (1984) Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 310(23):1500–1505. https://doi.org/10.1056/NEJM198406073102304
Murthy CR, Rama Rao KV, Bai G, Norenberg MD (2001) Ammonia-induced production of free radicals in primary cultures of rat astrocytes. J Neurosci Res 66(2):282–288. https://doi.org/10.1002/jnr.1222
Nassogne MC, Héron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28(3):407–414. https://doi.org/10.1007/s10545-005-0303-7
Nizon M, Ottolenghi C, Valayannopoulos V, Arnoux JB, Barbier V, Habarou F, Desguerre I, Boddaert N, Bonnefont JP, Acquaviva C, Benoist JF, Rabier D, Touati G, de Lonlay P (2013) Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias. Orphanet J Rare Dis 8:148. https://doi.org/10.1186/1750-1172-8-148
Norenberg MD (1998) Astroglial dysfunction in hepatic encephalopathy. Metab Brain Dis 13(4):319–335. https://doi.org/10.1023/A:1020688925901
Norenberg MD, Rama Rao KV, Jayakumar AR (2009) Signaling factors in the mechanism of ammonia neurotoxicity. Metab Brain Dis 24(1):103–117. https://doi.org/10.1007/s11011-008-9113-6
North KN, Hoppel CL, De Girolami U, Kozakewich HP, Korson MS (1995) Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 127(3):414–420. https://doi.org/10.1016/S0022-3476(95)70073-0
Ogier De Baulny H, Saudubray JM (2002) Branched-chain organic acidurias. Semin Neonatol 7:65–74. https://doi.org/10.1053/siny.2001.0087
Olpin SE (2013) Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability. J Inherit Metab Dis 36:645–658. https://doi.org/10.1007/s10545-013-9611-5
Ott P, Vilstrup H (2014) Cerebral effects of ammonia in liver disease: current hypotheses. Metab Brain Dis 29(4):901–911. https://doi.org/10.1007/s11011-014-9494-7
Ott P, Clemmesen O, Larsen FS (2005) Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem Int 47(1–2):13–18. https://doi.org/10.1016/j.neuint.2005.04.002
Patejunas G, Lee B, Dennis JA, Healy PJ, Reeds PJ, Yu H, Frazer M, Mull B, Warman AW, Beaudet AL, O’Brien WE (1998) Evaluation of gene therapy for citrullinaemia using murine and bovine models. J Inherit Metab Dis 21(Suppl 1):138–150. https://doi.org/10.1023/a:1005322010854
Peoc’h K, Damaj L, Pelletier R, Lefèvre C, Dubourg C, Denis MC, Bendavid C, Odent S, Moreau C (2020) Early care of N-acetyl glutamate synthase (NAGS) deficiency in three infants from an inbred family. Mol Genet Metab Rep 22:100558. https://doi.org/10.1016/j.ymgmr.2019.100558
Rama Rao KV, Norenberg MD (2012) Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochem Int 60(7):697–706. https://doi.org/10.1016/j.neuint.2011.09.007
Rama Rao KV, Jayakumar AR, Norenberg DM (2003) Ammonia neurotoxicity: role of the mitochondrial permeability transition. Metab Brain Dis 18(2):113–127. https://doi.org/10.1023/A:1023858902184
Rama Rao KV, Jayakumar AR, Tong X, Curtis KM, Norenberg MD (2010) Brain aquaporin-4 in experimental acute liver failure. J Neuropathol Exp Neurol 69(9):869–879. https://doi.org/10.1097/NEN.0b013e3181ebe581
Rangroo Thrane V, Thrane AS, Chang J, Alleluia V, Nagelhus EA, Nedergaard M (2012) Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy. Neuroscience 220:247–255. https://doi.org/10.1016/j.neuroscience.2012.06.022
Rangroo Thrane V, Thrane AS, Wang F, Cotrina ML, Smith NA, Chen M, Xu Q, Kang N, Fujita T, Nagelhus EA, Nedergaard M (2013) Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering. Nat Med 19(12):1643–1648. https://doi.org/10.1038/nm.3400
Ransohoff RM, Cardona AE (2010) The myeloid cells of the central nervous system parenchyma. Nature 468(7321):253–262. https://doi.org/10.1038/nature09615
Raper SE, Yudkoff M, Chirmule N et al (2002) A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther 13:163–175. https://doi.org/10.1089/10430340152712719
Ribas GS, Vargas CR (2020) Evidence that oxidative disbalance and mitochondrial dysfunction are involved in the pathophysiology of fatty acid oxidation disorders. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-020-00955-7
Ribas GS, Vargas CR, Wajner M (2014) L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene 533(2):469–476. https://doi.org/10.1016/j.gene.2013.10.017
Rinaldo P, Matern D, Bennett MJ (2002) Fatty acid oxidation disorders. Annu Rev Physiol 64:477–502. https://doi.org/10.1146/annurev.physiol.64.082201.154705
Rodrigo R, Cauli O, Boix J, ElMlili N, Agusti A, Felipo V (2009) Role of NMDA receptors in acute liver failure and ammonia toxicity: therapeutical implications. Neurochem Int 55(1–3):113–118. https://doi.org/10.1016/j.neuint.2009.01.007
Romero-Gómez M, Jover M, Galán JJ, Ruiz A (2009) Gut ammonia production and its modulation. Metab Brain Dis 24(1):147–157. https://doi.org/10.1007/s11011-008-9124-3
Rose C, Kresse W, Kettenmann H (2005) Acute insult of ammonia leads to calcium-dependent glutamate release from cultured astrocytes, an effect of pH. J Biol Chem 280(22):20937–20944. https://doi.org/10.1074/jbc.M412448200
Royes LF, Gabbi P, Ribeiro LR, Della-Pace ID, Rodrigues FS, de Oliveira Ferreira AP, da Silveira Junior ME, da Silva LR, Grisólia AB, Braga DV, Dobrachinski F, da Silva AM, Soares FA, Marchesan S, Furian AF, Oliveira MS, Fighera MR (2016) A neuronal disruption in redox homeostasis elicited by ammonia alters the glycine/glutamate (GABA) cycle and contributes to MMA-induced excitability. Amino Acids 48(6):1373–1389. https://doi.org/10.1007/s00726-015-2164-1
Saheki T, Kobayashi K (2002) Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 47(7):333–341. https://doi.org/10.1007/s100380200046
Saheki T, Kobayashi K, Iijima M, Moriyama M, Yazaki M, Takei Y, Ikeda S (2005) Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Hepatol Res 33(2):181–184. https://doi.org/10.1016/j.hepres.2005.09.031
Saparov SM, Liu K, Agre P, Pohl P (2007) Fast and selective ammonia transport by aquaporin-8. J Biol Chem 282(8):5296–5301. https://doi.org/10.1074/jbc.M609343200
Scaglia F, Zheng Q, O’Brien WE, Henry J, Rosenberger J, Reeds P, Lee B (2002) An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency. Pediatrics 109(1):150–152. https://doi.org/10.1542/peds.109.1.150
Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E (1999) Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transpl 14:910–918. https://doi.org/10.1093/ndt/14.4.910
Scriver C, Beaudt A, Sly W, Valle D (2001) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York
Sepehrinezhad A, Zarifkar A, Namvar G, Shahbazi A, Williams R (2020) Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema. Metab Brain Dis 35(4):559–578. https://doi.org/10.1007/s11011-020-00549-8
Sin YY, Baron G, Schulze A, Funk CD (2015) Arginase-1 deficiency. J Mol Med (berl) 93(12):1287–1296. https://doi.org/10.1007/s00109-015-1354-3
Sinke AP, Jayakumar AR, Panickar KS, Moriyama M, Reddy PV, Norenberg MD (2008) NFkappaB in the mechanism of ammonia-induced astrocyte swelling in culture. J Neurochem 106(6):2302–2311. https://doi.org/10.1111/j.1471-4159.2008.05549.x
Smith W, Diaz GA, Lichter-Konecki U, Berry SA, Harding CO, McCandless SE, LeMons C, Mauney J, Dickinson K, Coakley DF, Moors T, Mokhtarani M, Scharschmidt BF, Lee B (2013) Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate. J Pediatr 162(6):1228–1234. https://doi.org/10.1016/j.jpeds.2012.11.084
Sørensen M (2013) Update on cerebral uptake of blood ammonia. Metab Brain Dis 28(2):155–159. https://doi.org/10.1007/s11011-013-9395-1
Soria LR, Ah Mew N, Brunetti-Pierri N (2019) Progress and challenges in development of new therapies for urea cycle disorders. Hum Mol Genet 28(R1):R42–R48. https://doi.org/10.1093/hmg/ddz140
Spada M, Porta F, Righi D, Gazzera C, Tandoi F, Ferrero I, Fagioli F, Sanchez MBH, Calvo PL, Biamino E, Bruno S, Gunetti M, Contursi C, Lauritano C, Conio A, Amoroso A, Salizzoni M, Silengo L, Camussi G, Romagnoli R (2020) Intrahepatic administration of human liver stem cells in infants with inherited neonatal-onset hyperammonemia: a phase I study. Stem Cell Rev Rep 16(1):186–197. https://doi.org/10.1007/s12015-019-09925-z
Stewart CA, Smith GE (2007) Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 4(12):677–685. https://doi.org/10.1038/ncpgasthep0999
Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, Posner MP (1997) Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63(4):559–569. https://doi.org/10.1097/00007890-199702270-00014
Suárez I, Bodega G, Fernández B (2002) Glutamine synthetase in brain: effect of ammonia. Neurochem Int 41(2–3):123–142. https://doi.org/10.1016/S0197-0186(02)00033-5
Summar M (2001) Current strategies for the management of neonatal urea cycle disorders. J Pediatr 138(1 Suppl):S30–S39. https://doi.org/10.1067/mpd.2001.111834
Summar ML, Mew NA (2018) Inborn errors of metabolism with hyperammonemia: urea cycle defects and related disorders. Pediatr Clin North Am 65(2):231–246. https://doi.org/10.1016/j.pcl.2017.11.004
Summar ML, Koelker S, Freedenberg D, Le Mons C, Haberle J, Lee HS, Kirmse B (2013) The incidence of urea cycle disorders. Mol Genet Metab 110(1–2):179–180. https://doi.org/10.1016/j.ymgme.2013.07.008
Tanigami H, Rebel A, Martin LJ, Chen TY, Brusilow SW, Traystman RJ, Koehler RC (2005) Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience 131(2):437–449. https://doi.org/10.1016/j.neuroscience.2004.10.045
Tchan M (2018) Hyperammonemia and lactic acidosis in adults: differential diagnoses with a focus on inborn errors of metabolism. Rev Endocr Metab Disord 19(1):69–79. https://doi.org/10.1007/s11154-018-9444-5
Thomas JA (2015) Organic acidemias. In: Bernstein LE, Helm JR, Rohr F (eds) Nutrition management of inherited metabolic disease: lessons from metabolic university. Springer International Publishing, Switzerland, pp 187–201
Tofteng F, Larsen FS (2004) The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 24(7):798–804. https://doi.org/10.1097/01.WCB.0000125648.03213.1D
Tomomura M, Tomomura A, Musa DA, Horiuchi M, Takiguchi M, Mori M, Saheki T (1997) Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood. J Biochem 121(1):172–177. https://doi.org/10.1093/oxfordjournals.jbchem.a021562
Truong B, Allegri G, Liu XB, Burke KE, Zhu X, Cederbaum SD, Häberle J, Martini PGV, Lipshutz GS (2019) Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency. Proc Natl Acad Sci USA 116(42):21150–21159. https://doi.org/10.1073/pnas.1906182116
Tsuboi Y, Fujino Y, Kobayashi K, Saheki T, Yamada T (2001) High serum pancreatic secretory trypsin inhibitor before onset of type II citrullinemia. Neurology 57(5):933. https://doi.org/10.1212/WNL.57.5.933
Tuchman M, Lee B, Lichter-Konecki U, Summar ML, Yudkoff M, Cederbaum SD, Kerr DS, Diaz GA, Seashore MR, Lee HS, McCarter RJ, Krischer JP, Batshaw ML (2008) Urea cycle disorders consortium of the rare diseases clinical research network. Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab 94(4):397–402. https://doi.org/10.1016/j.ymgme.2008.05.004
Uchino T, Endo F, Matsuda I (1998) Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis 21(Suppl 1):151–159. https://doi.org/10.1023/A:1005374027693
Valle D, Simell O (2001) The hyperornithinemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw Hill, New York, pp 1857–1896
Van Hall G, van der Vusse GJ, Söderlund K, Wagenmakers AJ (1995) Deamination of amino acids as a source for ammonia production in human skeletal muscle during prolonged exercise. J Physiol 489:251–261. https://doi.org/10.1113/jphysiol.1995.sp021047
Viegas CM, Zanatta Â, Grings M, Hickmann FH, Monteiro WO, Soares LE, Sitta Â, Leipnitz G, de Oliveira FH, Wajner M (2014) Disruption of redox homeostasis and brain damage caused in vivo by methylmalonic acid and ammonia in cerebral cortex and striatum of developing rats. Free Radic Res 48(6):659–669. https://doi.org/10.3109/10715762.2014.898842
Villani GR, Gallo G, Scolamiero E, Salvatore F, Ruoppolo M (2017) “Classical organic acidurias”: diagnosis and pathogenesis. Clin Exp Med 17:305–323. https://doi.org/10.1007/s10238-016-0435-0
Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60(2):715–735. https://doi.org/10.1002/hep.27210
Vince AJ, Burridge SM (1980) Ammonia production by intestinal bacteria: the effects of lactose, lactulose and glucose. J Med Microbiol 13(2):177–191
Vishwanath V (2016) Fatty acid beta-oxidation disorders: a brief review. Ann Neurosci 23:51–55. https://doi.org/10.1159/000443556
Wajner M (2019) Neurological manifestations of organic acidurias. Nat Rev Neurol 15(5):253–271. https://doi.org/10.1038/s41582-019-0161-9
Wajner M, Amaral AU (2015) Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies. Biosci Rep 36:e00281. https://doi.org/10.1042/BSR20150240
Wajner M, Sitta A, Kayser A, Deon M, Groehs AC, Coelho DM, Vargas CR (2019) Screening for organic acidurias and aminoacidopathies in high-risk Brazilian patients: eleven-year experience of a reference center. Genet Mol Biol 42(1 suppl 1):178–185. https://doi.org/10.1590/1678-4685-GMB-2018-0105
Wajner M, Vargas CR, Amaral AU (2020) Disruption of mitochondrial functions and oxidative stress contribute to neurologic dysfunction in organic acidurias. Arch Biochem Biophys 696:108646. https://doi.org/10.1016/j.abb.2020.108646
Walker V (2009) Ammonia toxicity and its prevention in inherited defects of the urea cycle. Diabetes Obes Metab 11(9):823–835. https://doi.org/10.1111/j.1463-1326.2009.01054.x
Walker V (2014) Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem 67:73–150. https://doi.org/10.1016/bs.acc.2014.09.002
Wang L, Wang H, Morizono H, Bell P, Jones D, Lin J, McMenamin D, Yu H, Batshaw ML, Wilson JM (2012) Sustained correction of OTC deficiency in spf (ash) mice using optimized self-complementary AAV2/8 vectors. Gene Ther 19(4):404–410. https://doi.org/10.1038/gt.2011.111
Weber FL Jr, Banwell JG, Fresard KM, Cummings JH (1987) Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin. J Lab Clin Med 110(3):259–263
Weiner ID, Verlander JW (2013) Renal ammonia metabolism and transport. Compr Physiol 3(1):201–220. https://doi.org/10.1002/cphy.c120010
Weiner ID, Mitch WE, Sands JM (2015) Urea and ammonia metabolism and the control of renal nitrogen excretion. Clin J Am Soc Nephrol 10(8):1444–1458. https://doi.org/10.2215/CJN.10311013
Willard-Mack CL, Koehler RC, Hirata T, Cork LC, Takahashi H, Traystman RJ, Brusilow SW (1996) Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience 71(2):589–599. https://doi.org/10.1016/0306-4522(95)00462-9
Ye X, Robinson MB, Batshaw ML, Furth EE, Smith I, Wilson JM (1996) Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J Biol Chem 271(7):3639–3646. https://doi.org/10.1074/jbc.271.7.3639
Zielińska M, Ruszkiewicz J, Hilgier W, Fręśko I, Albrecht J (2011) Hyperammonemia increases the expression and activity of the glutamine/arginine transporter y+ LAT2 in rat cerebral cortex: implications for the nitric oxide/cGMP pathway. Neurochem Int 58(2):190–195. https://doi.org/10.1016/j.neuint.2010.11.015
Zwingmann C, Chatauret N, Leibfritz D, Butterworth RF (2003) Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. Hepatology 37(2):420–428. https://doi.org/10.1053/jhep.2003.50052
Acknowledgements
This work was supported by Brazilian Foundation Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Fundo de Incentivo à Pesquisa e Eventos (FIPE/HCPA).
Funding
No specific source of funding is associated with this work.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare there are no conflicts of interest.
Ethical Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ribas, G.S., Lopes, F.F., Deon, M. et al. Hyperammonemia in Inherited Metabolic Diseases. Cell Mol Neurobiol 42, 2593–2610 (2022). https://doi.org/10.1007/s10571-021-01156-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-021-01156-6